Inhibikase Pharma (IKT) - Amount of Cash per Share

Corporate emblem and logo of Inhibikase Therapeutics (IKT)

Stable Western jurisdictions and the humanitarian status of its developments minimize external risks for Inhibikase Therapeutics (IKT). This cash position per share chart confirms this trend, where 1.39 describes the current status of the metric. Innovations in blocking the c-Abl enzyme to combat Parkinson's disease are complemented by streamlined biomaterial logistics via a network of contract laboratories, supporting high business profitability.

IKT Inhibikase Therapeutics Inc: Cash Funds per Share in the range 07/04/2022 - 11/21/2026

Analytical breakdowns for Inhibikase Therapeutics

- share price and consensus valuation forecast:
Summary company analysis:IKT (Inhibikase Therapeutics)
Core merchandise of Inhibikase Pharma

This indicator determines the volume of liquid assets per common share, allowing for an assessment of the internal value of capital and the issuer's financial autonomy. By analyzing the cash per share trend, an investor can see the burn rate of reserves required by Inhibikase Therapeutics (IKT) to fund multi-stage clinical trials of small molecules for the treatment of neurodegenerative pathologies.

Competing companies

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Cassava Sciences, Inc.|ASRT (assertiotx.com) - Cash Calculated per Single Share|Cash Funds per Share Coya (COYA)|VTGN - Cash on Hand per Share|Cash per Share OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Cash on Hand per Share|cervomed.com - Cash per Share|Amount of Cash per Share ATHE (Alterity Therapeutics Limited)|CLNN: Cash per Share|Cash per Single Share PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Cash per Share|Cash on Hand per Share Relmada Therapeutics Inc RLMD|Cash Funds per Share Annovis Bio Corporation (ANVS)|GRCE - Cash on Hand per Share|Cash Funds per Share Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Cash on Hand per Share|NeuroSense Therapeutics, Ltd. - Cash per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share